medigraphic.com

2011, Number S1

<< Back Next >>

Rev Mex Anest 2011; 34 (S1)

Agonist mu intra-operative combination through intravenous via: Fentanyl-Sufentanyl

Martínez-Baltazar YI, Muñoz-Cuevas JH

Language: Spanish
References: 21
Page: 200-205
PDF size: 643.72 Kb.


Text Extraction

No abstract


REFERENCES

  1. Aguilera L. Importancia de los parámetros farmacocinéticos y farmacodinámicos en las interacciones farmacológicas, Rev Esp Anestesiol Reanim 2003:50:251-2.

  2. Kazama T. Reduction by fentanyl of the CP50 values of propofol and hemodynamic responses to various noxious stimuli. Anesthesiology 1997;87:213-217.

  3. Kazama T, et al. The pharmacodynamic interaction between propofol an fentanyl with respect to the suppression of somatic or hemodynamic responses to skin incision, peritoneum incision and abdominal wall retraction. Anesthesiology 1998;89:894-906.

  4. Muñoz-Cuevas JH. Anestesia basada en analgesia. Rev Mex de Anestesiología 2007;(30 Supl 1):S180-S184.

  5. Rivera R, Antognioni JF. Perioperative drug therapy in elderly patients. Anesthesiology 2009;110:1176-1181.

  6. White P, Kehlet H. The role of the anesthesiologist in fast-track surgery: From multimodal analgesia to perioperative medical care. Anesth-Analg 2007;104:1380-1396.

  7. Hughes M, Glass P. Context-sensitive half-tima in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992;76:334-341.

  8. Peng P, Sandler A. A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology 1999;90:576-599.

  9. Philbin DM. Fentanyl an sufentanyl anaesthesia revisted: How much is enough? Anesthesiology 1990;75:5-11.

  10. Trescot. Opioid pharmacology. Pain Physician 2008: Opioid Special Issue: 11: S133-S153 • ISSN 1533-3159.

  11. Smith. Combination opioid analgesics. Pain physician 2008;11:201-214 • ISSN 1533-3159.

  12. Ortiz JR, Lora-Tamayo J. Opiáceos. Fentanilo, alfentanilo, sufentanilo, remifentanilo. Anestesia total intravenosa. Principios básicos. Aguilar Luciano. Bbraun Medical SA. Impreso S.A. de Litografía 2009.

  13. Alfaro-Llamas J. Perfusión intravenosa de opioides en el transoperatorio. Administración de opioides potentes. Sufentanyl. Rev Mex de Anestesiología 2007;(30 Supl. 1):S174-S179.

  14. Diccionario de la Real Academia Española.

  15. Hendrickx. Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility. Anesthesia & analgesia international anesthesia research society. 2008;107:499-506.

  16. Shafer. Additivity versus synergy: a theoretical analysis of implications for anesthetic mechanisms. Anesthesia & Analgesia 2008;107:507-524.

  17. Yeh. Combination of opioid agonist and agonist–antagonist: patient-controlled analgesia requirement and adverse events among different-ratio morphine and nalbuphine admixtures for postoperative pain. British Journal of Anaesthesia 2008;101:542-8.

  18. Fidler. Flexible interaction model for complex interactions of multiple anesthetics, anesthesiology 2006;105:286-96.

  19. Gept. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 1995;83:1194-1204.

  20. Ramsin. Opioid complications and side effects. Pain physician 2008: opioid special issue: 11:s105-s120 • issn 1533-3159.

  21. Slepchenko. Performance of target-controlled sufentanyl infusion in obese patients. Anesthesiology 2003;98:65-73




2020     |     www.medigraphic.com